Summary

Acutaas Chemicals Limited announced strong financial results for the fourth quarter and full year ended March 31, 2026. For Q4 FY26, revenue from operations significantly grew by 40.3% year-on-year to ₹4,328 million, while Profit After Tax (PAT) more than doubled, increasing by 114.1% to ₹1,343 million, with PAT margins reaching a record 31.0%. The full financial year FY26 also saw robust performance, with revenue growing 33.0% to ₹13,394 million and PAT soaring by 122.2% to ₹3,564 million. Executive Chairman & Managing Director, Mr. Naresh Patel, expressed pleasure with the strong close to FY26 and highlighted the company's strategy to build a diversified chemicals business across high-growth verticals, projecting confidence in achieving 25% revenue growth in FY27.

Key Highlights

1. 1

   Acutaas Chemicals Limited reported a robust Q4 FY26 revenue from operations of ₹4,328 million, marking a significant 40.3% increase year-on-year.

2. 2

   Profit After Tax (PAT) for Q4 FY26 surged by 114.1% year-on-year to ₹1,343 million, with PAT margins reaching an all-time high of 31.0%.

3. 3

   For the full financial year 2026, revenue from operations grew by 33.0% to ₹13,394 million.

4. 4

   Full-year FY26 PAT demonstrated exceptional growth, soaring by 122.2% to ₹3,564 million.

5. 5

   EBITDA for Q4 FY26 was strong at ₹1,835 million, representing a 116.0% increase year-on-year, and EBITDA margin improved to 42.4%.

6. 6

   The company is strategically diversifying its business across three high-growth verticals: Battery Chemicals, Semiconductors, and Pharmaceutical CDMO.

7. 7

   Management expressed confidence in delivering 25% revenue growth in FY27, entering the year from a position of strength.